Vulcan Energy: A Well That Beat Its Target, a Shareholder Filing That Wasn't a Purchase, and a Date in Late October

Canaccord Genuity has reiterated its speculative buy rating on Vulcan Energy, and the reasoning behind it rests on a single technical milestone rather than any shift in the project calendar. The broker's note, reported in the media, argues that the recent reinjection test bolsters confidence in the assumptions underpinning Lionheart. For investors, the takeaway is the de-risking of a planning figure — not a revised timeline.

The test in question involved the LSC-3a reinjection well. Vulcan Energy reported roughly a week ago that lithium-depleted brine had been successfully returned to the sandstone matrix. Under the planned operating conditions, the interpreted injection capacity came in at approximately 64 standard litres per second, against the roughly 40 standard litres per second assumed for matrix injectors in the Lionheart development plan.

That result shores up a central project assumption. Its weight lies in the return of brine under the conditions actually envisaged for operations — and it should not be equated with commissioning of the wider project. The distinction matters: Vulcan describes a capacity derived from the test under intended operating conditions, not a record of economic output, revenue or profit.

A second workstream, and a separate disclosure

Vulcan also announced on 8 October that commercial-scale production of its lithium extraction material VULSORB had begun in Germany. The first volumes are earmarked for the initial fill of Lionheart's extraction columns, with commissioning of those columns scheduled for the second half of 2028. That announcement concerns preparation of the plant, not the start of operations, and the two developments are best kept apart rather than rolled into a single proof of overall project progress.

Then there is the Citigroup filing, which requires just as careful a reading. Around two weeks ago, the reported voting stake rose from 7.1056% to 8.1917%. The mandatory disclosure attributes the interests shown to securities lending and customary market contracts. A higher percentage therefore does not establish a direct share purchase as an investment decision — reading the notice as an unambiguous vote of confidence from a major investor goes beyond what it actually says. What counts here is not only the direction of the change but the contractual backdrop behind it.

What the share price did, and what it doesn't tell you

Against this backdrop of technical progress, the stock has remained weak. Yesterday's daily move was -2.3%. Neither the drilling result nor the stake disclosure offers an immediate explanation for that decline, and the technical success cannot be used to account for it.

The useful framework is to separate project advancement from price action. The test supplies concrete evidence for a technical assumption; the analyst rating places that evidence in a positive light but substitutes neither for further implementation steps nor for eventual operations. The Citigroup notice, meanwhile, describes attributed voting rights — relevant information, but not the same thing as a purchase.

Canaccord's speculative buy tag is itself a meaningful caveat: it is no guarantee of how the project will unfold from here. The next scheduled date on the corporate calendar is the September quarterly report on 28 October, which will give investors the next formal update on the company's reporting. Until then, the picture is one of concrete technical strides within an unchanged plan — a better-supported assumption, with commissioning still a planned future step.